We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Carcinoma of the Cervix FREE

John L. Zeller, MD, PhD, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor
JAMA. 2007;298(19):2336. doi:10.1001/jama.298.19.2336.
Text Size: A A A
Published online

Half of all cancers of the cervix (the lower part of the uterus [womb]) occur in women between the ages of 35 and 55 years. Every year more than 11 000 women in the United States are diagnosed with invasive cervical cancer, and nearly 4 000 will die from complications of this disease. Cervical cancer is preventable and curable if detected early. The November 21, 2007, issue of JAMA includes an article describing the use of careful follow-up and an imaging test called fluorine-18-labeled deoxyglucose-positron-emission tomographic scan (FDG-PET), a nuclear medicine scan that detects uptake of glucose by tumor cells, to assess tumor response to therapy, to predict survival outcomes, and to detect early recurrence of tumor cells.


  • Human papillomavirus infection—various strains of the human papillomavirus (HPV), a sexually transmitted viral infection, play a role in causing most cases of cervical cancer. A vaccine is now available that has the potential to prevent HPV infection in women.

  • Sexual history—multiple sexual partners, sexual activity in adolescent girls

  • Sexually transmitted diseases (STDs)—chlamydia, gonorrhea, syphilis, or HIV/AIDS increase the chance of acquiring HPV

  • Weak immune system, such as from HIV infection

  • Cigarette smoking—tobacco use increases the risk of precancerous changes


Regular screening for cervical cancer is recommended for all women. It should begin within 3 years of becoming sexually active or no later than age 21. In addition to a medical history and physical examination, screening may include

  • Papanicolaou (PAP) test—a test to detect abnormal cells in the cervix

  • HPV DNA test—a lab test that detects the most common types of HPV that are likely to lead to cervical cancer

If a woman has an abnormal PAP test result, additional tests are needed to confirm the diagnosis, determine the extent of the cancer, and direct treatment options.

  • Colposcopy—a special microscope that examines the cervix for abnormal cells

  • Biopsy—removal of small samples of tissue for examination

  • Visual examination of the bladder and colon by special scopes to examine inside the bladder (cytoscopy) and the lower part of the large intestine (proctoscopy) to determine the extent and possible spread of cancer to surrounding organs.

  • Imaging studies—chest x-ray, CT, MRI, and PET to determine the presence and potential spread of cancer cells


The choice of treatment and the long-term outcome of cancer of the cervix depend on the type and stage of cancer as well as physician recommendation and patient choice. The main treatment options for cervical cancer are surgery, radiation therapy, and chemotherapy.



To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on human papillomavirus was published in the February 28, 2007, issue.

Sources: American Cancer Society, National Women's Health Information Center.

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 203/259-8724.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles